People and Culture Cristin Hubbard Reflects on a Career Spent Bringing Innovation to Patients – and Why Working at BioMarin Has Her More Energized Than Ever August 7, 2026
People and Culture Cristin Hubbard Reflects on a Career Spent Bringing Innovation to Patients – and Why Working at BioMarin Has Her More Energized Than Ever August 7, 2026
Community Why Do I Pheel This Way? Episode 3: Finding Strength Through Sports While Living with Phenylketonuria June 25, 2026
Community Why Do I Pheel This Way? Episode 2 Explores Social Life, Support and Self-Advocacy for Teens with Phenylketonuria June 11, 2026
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin’s Pipeline August 18, 2026
BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston August 10, 2026
BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET July 30, 2026
BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome July 27, 2026